ОбзорГрафикНовостиTraderScreen

BVT Aktienanleihe TSLA 27.09.2024/  DE000VU95704  /

EUWAX
16.05.2024  9:48:20 Изменение-1.47 Бид21:59:12 Предложение21:59:12 Базовый актив Цена исполнения Дата истечения Тип опциона
66.55EUR -2.16% 66.51
Величина цены спроса: 500,000		 66.61
Величина цены предложения: 500,000		 Tesla Inc 300.00 USD 27.09.2024 Call
GlobeNewswire 22:12 Kadant Declares Cash Dividend
GlobeNewswire 22:12 African Business Leaders Pledge to tackle Gender Inequality at the Africa CEO Forum
GlobeNewswire 22:05 Fortrea Appoints Machelle Sanders to Board of Directors
GlobeNewswire 22:05 NextNav Announces Appointment of Jonathan Marcus to Board of Directors
Newsfile Corp 22:05 F3 Announces Revised Pricing of Bought Deal Private Placement for Gross Proceeds of Over C$10.0 Mill...
GlobeNewswire 22:05 PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders
GlobeNewswire 22:05 Rapid7 to Attend Upcoming Investor Conferences
GlobeNewswire 22:05 ArriVent Appoints John Hohneker, M.D., to its Board of Directors
GlobeNewswire 22:05 Option Care Health to Participate in Upcoming Investor Conferences
GlobeNewswire 22:05 Earlyworks Announces Completion of ADS Ratio Change
GlobeNewswire 22:05 Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
GlobeNewswire 22:05 Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 22:05 Epsilon Announces 2024 AGM Results
GlobeNewswire 22:05 Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference
GlobeNewswire 22:05 Merit Medical Shareholders Elect Silvia M. Perez as New Director
GlobeNewswire 22:05 ZimVie to Participate in Upcoming Investor Conferences
GlobeNewswire 22:05 TEN Ltd. Announces Delivery of Six Environmentally Friendly Vessels Since the Beginning of 2024
GlobeNewswire 22:05 New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benef...
GlobeNewswire 22:05 Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and...
GlobeNewswire 22:05 Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference
GlobeNewswire 22:05 Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
GlobeNewswire 22:02 Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care ...
GlobeNewswire 22:01 Unity Bancorp Declares Cash Dividend
GlobeNewswire 22:01 Rent the Runway to Report First Quarter 2024 Results on June 6, 2024
GlobeNewswire 22:01 FormFactor Announces Participation at Upcoming Conferences